These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27541380)

  • 1. The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus: Rationale and Design of RosCal Study.
    Zhang W; Luan Y; Jin C; Xu S; Bi X; Zhao Y; Qiu F; Fu G; Wang M
    Clin Drug Investig; 2016 Dec; 36(12):1023-1029. PubMed ID: 27541380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.
    Lemos MM; Watanabe R; Carvalho AB; Jancikic AD; Sanches FM; Christofalo DM; Draibe SA; Canziani ME
    Clin Nephrol; 2013 Jul; 80(1):1-8. PubMed ID: 23442255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
    Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
    Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
    EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
    Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ
    N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
    Hong MK; Park DW; Lee CW; Lee SW; Kim YH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2009 Jul; 2(7):679-88. PubMed ID: 19628193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus.
    Kiramijyan S; Ahmadi N; Isma'eel H; Flores F; Shaw LJ; Raggi P; Budoff MJ
    Am J Cardiol; 2013 Feb; 111(3):356-61. PubMed ID: 23206921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
    JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study.
    Zeb I; Li D; Nasir K; Malpeso J; Batool A; Flores F; Dailing C; Karlsberg RP; Budoff M
    Atherosclerosis; 2013 Dec; 231(2):198-204. PubMed ID: 24267226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic association of diabetes-associated genetic risk score with rapid progression of coronary artery calcification following treatment with HMG-CoA-reductase inhibitors -results of the Heinz Nixdorf Recall Study.
    Pechlivanis S; Jung D; Moebus S; Lehmann N; Mahabadi AA; Hoffmann P; Erbel R; Nöthen MM; Bachmann HS
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1713-1725. PubMed ID: 34021798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management.
    Goh VK; Lau CP; Mohlenkamp S; Rumberger JA; Achenbach S; Budoff MJ
    Cardiovasc Ultrasound; 2010 Mar; 8():5. PubMed ID: 20226020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and progression of coronary calcium under the influence of statin therapy.
    Budoff MJ; Yu D; Nasir K; Mehrotra R; Chen L; Takasu J; Agrawal N; Liu ST; Blumenthal RS
    Am Heart J; 2005 Apr; 149(4):695-700. PubMed ID: 15990755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
    Ovrakh T; Serik S; Kochubiei O
    Georgian Med News; 2017 Apr; (265):7-14. PubMed ID: 28574378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.